Carl O'Donnell

@CarlODonnell26

I cover pharmaceutical companies for Reuters.

Vrijeme pridruživanja: rujan 2013.

Tweetovi

Blokirali ste korisnika/cu @CarlODonnell26

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CarlODonnell26

  1. prije 7 sati

    FOCUS-Drugmakers see long road ahead in coronavirus vaccine race w/

    Poništi
  2. proslijedio/la je Tweet
    16. sij

    Celebrating the 30-year anniversary of Richard Chang and the 40th of at !

    Poništi
  3. 16. sij

    Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020:...

    Poništi
  4. 9. sij

    Bristol-Myers confident of approvals linked to higher Celgene payout... w/

    Poništi
  5. proslijedio/la je Tweet
    1. sij

    More drugmakers hike U.S. prices as new year begins

    Poništi
  6. proslijedio/la je Tweet
    1. sij

    More Jan.1 price increases this morning including Bristol-Myers , Gilead , and Biogen :

    Prikaži ovu nit
    Poništi
  7. proslijedio/la je Tweet
    1. sij
    Prikaži ovu nit
    Poništi
  8. proslijedio/la je Tweet
    31. pro 2019.

    Exclusive: Drugmakers from Pfizer to GSK to hike U.S. prices on... via

    Poništi
  9. 31. pro 2019.

    Exclusive: Drugmakers from Pfizer to GSK to hike U.S. prices on... w/

    Poništi
  10. proslijedio/la je Tweet
    20. pro 2019.

    Novartis wins Medicaid approval for new sickle cell drug in key U.S. states

    Poništi
  11. proslijedio/la je Tweet
    20. pro 2019.

    Things are changing for patients, with 2 new drugs winning US approval in Nov. But access for most means securing Medicaid coverage, which can take as long as 12 to 18 months. Novartis has been cleared in two states already.

    Poništi
  12. 20. pro 2019.

    Novartis wins Medicaid approval for new sickle cell drug w/

    Poništi
  13. 18. pro 2019.

    Trump proposes rule for importing drugs from Canada; industry says...

    Poništi
  14. proslijedio/la je Tweet
    17. pro 2019.

    Pavel always captures the most stunning Kazakh landscapes: The sun emerges on a foggy day after snowfall in Almaty, December 16, 2019. /Pavel Mikheyev

    Poništi
  15. proslijedio/la je Tweet
    16. pro 2019.

    Best of 2019: Twelve Corgis are on call at Bangkok cafe

    Poništi
  16. proslijedio/la je Tweet
    10. pro 2019.

    Nice! My first industrial scoop (& first co-byline w/ ) was confirmed this morning. Goldman's SPAC, led by the former Honeywell CEO, has a deal for Vertiv that values the business at $5.3 billion.

    Poništi
  17. 7. pro 2019.

    Bristol-Myers reports positive data on cancer treatment acquired in...

    Poništi
  18. 5. pro 2019.

    FDA probes diabetes drug metformin for carcinogen NDMA

    Poništi
  19. 5. pro 2019.

    Eli Lilly to put Loxo executives in charge of new cancer research unit

    Poništi
  20. 3. pro 2019.

    Johnson & Johnson says new tests show no asbestos in Johnson's Baby...

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·